Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 705

1.

Comparison of two different models of anticoagulation management services with usual medical care.

Rudd KM, Dier JG.

Pharmacotherapy. 2010 Apr;30(4):330-8. doi: 10.1592/phco.30.4.330.

PMID:
20334453
2.

Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.

Hall D, Buchanan J, Helms B, Eberts M, Mark S, Manolis C, Peele P, Docimo A.

Pharmacotherapy. 2011 Jul;31(7):686-94. doi: 10.1592/phco.31.7.686.

PMID:
21923456
3.

International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic.

Griffin BL, Burkiewicz JS, Peppers LR, Warholak TL.

Am J Health Syst Pharm. 2009 Jul 1;66(13):1218-23. doi: 10.2146/ajhp080278.

PMID:
19535661
4.
5.
6.

Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.

Wong YM, Quek YN, Tay JC, Chadachan V, Lee HK.

J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.

PMID:
21070296
7.
8.

The impact of pharmacist-managed oral anticoagulation therapy in older veterans.

Poon IO, Lal L, Brown EN, Braun UK.

J Clin Pharm Ther. 2007 Feb;32(1):21-9.

PMID:
17286786
9.

Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician.

Bungard TJ, Ritchie B, Garg S, Tsuyuki RT.

Pharmacotherapy. 2012 Feb;32(2):112-9. doi: 10.1002/PHAR.1011.

PMID:
22392419
10.
11.

Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis.

Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI.

Am J Health Syst Pharm. 2009 May 15;66(10):916-25. doi: 10.2146/ajhp080507.

PMID:
19420310
12.

Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists.

Airee A, Guirguis AB, Mohammad RA.

Ann Pharmacother. 2009 Apr;43(4):621-8. doi: 10.1345/aph.1L460. Epub 2009 Mar 24.

PMID:
19318602
13.

Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study.

Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H.

Pharmacotherapy. 2009 Dec;29(12):1433-40. doi: 10.1592/phco.29.12.1433.

PMID:
19947803
14.

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.

Menzin J, Boulanger L, Hauch O, Friedman M, Marple CB, Wygant G, Hurley JS, Pezzella S, Kaatz S.

Ann Pharmacother. 2005 Mar;39(3):446-51. Epub 2005 Feb 8.

PMID:
15701783
15.

Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care.

Aziz F, Corder M, Wolffe J, Comerota AJ.

J Vasc Surg. 2011 Nov;54(5):1404-7. doi: 10.1016/j.jvs.2011.05.021. Epub 2011 Jul 13.

16.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
17.
18.
19.

Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients.

Tschol N, Lai DK, Tilley JA, Wong H, Brown GR.

Can J Cardiol. 2003 Nov;19(12):1413-7.

PMID:
14631476
20.

Outcome analysis of a pharmacist-managed anticoagulation service.

Wilt VM, Gums JG, Ahmed OI, Moore LM.

Pharmacotherapy. 1995 Nov-Dec;15(6):732-9.

PMID:
8602380

Supplemental Content

Support Center